Catalyst Wire Dossier Catalyst Wire Dossier

Dalfampridine

dalfampridine · Ascend Laboratories, LLC
Drug timelines are a Plus or Pro feature.

36 regulatory and trial events tracked for Dalfampridine, covering 2013-10-14 to 2026-08-10. Get the full timeline:

Most recent: FDA Approved: DALFAMPRIDINE — Supplemental Application (Micro Labs Limited)

See pricing